AlphaFold predicted structure
MMP9 · P14780

Mean pLDDT
82.1/ 100
Confident
707 residues
Confidence breakdown
- Very high(≥ 90)49%
- Confident(70–90)33%
- Low(50–70)5%
- Very low(< 50)13%
AlphaFold (Jumper et al., 2021) · CC BY 4.0
matrix metallopeptidase 9
Annotations refreshed 9 hours ago.
Moderate Evidence (Amber)
Fetal anomalies
BIALLELIC, autosomal or pseudoautosomalSkeletal dysplasia
BIALLELIC, autosomal or pseudoautosomalFamilial Meniere Disease
Osteogenesis imperfecta
metaphyseal anadysplasia
dengue disease
Crohn disease
intervertebral disk degenerative disorder
non-small cell lung carcinoma
gastric adenocarcinoma
ulcerative colitis
breast cancer
prostate cancer
COVID-19
Score is the Open Targets composite evidence score (0-1). Higher = stronger gene-disease association.
Matrix metalloproteinase-9
Matrix metalloproteinase that plays an essential role in local proteolysis of the extracellular matrix and in leukocyte migration (PubMed:12879005, PubMed:1480034, PubMed:2551898). Could play a role in bone osteoclastic resorption (By similarity). Cleaves KiSS1 at a Gly-|-Leu bond (PubMed:12879005). Cleaves NINJ1 to generate the Secreted ninjurin-1 form (PubMed:32883094). Cleaves type IV and type V collagen into large C-terminal three quarter fragments and shorter N-terminal one quarter fragments (PubMed:1480034). Degrades fibronectin but not laminin or Pz-peptide
MMP9 · P14780

Mean pLDDT
82.1/ 100
Confident
707 residues
Confidence breakdown
AlphaFold (Jumper et al., 2021) · CC BY 4.0